Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A plasmid-encoded H-NS protein selectively binds its own plasmid.

bioRxiv : the preprint server for biology·2026
Same author

First-in-Human Evaluation of the Safety, Genetic Stability, and Immunogenicity of an Attenuated Shigella flexneri 2a Live Vector Expressing Enterotoxigenic Escherichia coli Antigens, Vaccine Strain CVD 1208S-122.

The Journal of infectious diseases·2026
Same author

Lipoprotein Lpp and L, D-transpeptidases regulate the master regulator of virulence AggR in EAEC.

Scientific reports·2025
Same author

CD45-mediated apoptosis and IL-2 receptor downregulation by serine proteases secreted from diarrheagenic bacteria.

bioRxiv : the preprint server for biology·2025
Same author

Characterization of <i>Shigella flexneri</i> serotype 6 strains from geographically diverse low- and middle-income countries.

mBio·2024
Same author

The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of abstract-based presentations.

Vaccine·2023

Related Experiment Video

Updated: Jun 18, 2026

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis
06:09

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis

Published on: September 30, 2017

Vaccines against tularemia.

Eileen M Barry1, Leah E Cole, Araceli E Santiago

  • 1University of Maryland School of Medicine, Center for Vaccine Development, Baltimore, MD, USA. ebarry@medicine.umaryland.edu

Human Vaccines
|November 20, 2009
PubMed
Summary

Francisella tularensis vaccine development is a priority due to its status as a Category A select agent. This review details progress on acellular subunit, killed whole cell, and live attenuated vaccine candidates.

Area of Science:

  • Microbiology and Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Francisella tularensis is a Category A select agent, necessitating urgent vaccine and countermeasure development.
  • Recent research has significantly expanded our understanding of this pathogen and its host cell interactions.

Purpose of the Study:

  • To review and summarize the progress and potential of various vaccine candidates against Francisella tularensis.
  • To consolidate recent advancements in the field of tularemia vaccine research.

Main Methods:

  • Literature review of recent studies on Francisella tularensis.
  • Analysis of data on acellular subunit, killed whole cell, and live attenuated vaccine candidates.
  • Synthesis of information on pathogen-host interactions relevant to vaccine efficacy.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Related Experiment Videos

Last Updated: Jun 18, 2026

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis
06:09

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis

Published on: September 30, 2017

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Main Results:

  • Multiple vaccine strategies are under investigation, including acellular subunit, killed whole cell, and live attenuated approaches.
  • Significant new data on Francisella tularensis and host interactions have emerged.
  • Various vaccine candidates show promise for future development.

Conclusions:

  • The development of effective vaccines against Francisella tularensis is progressing.
  • Continued research into different vaccine platforms is crucial for addressing the threat posed by this pathogen.
  • Understanding pathogen-host interactions is key to successful vaccine design.